(S (NP (NN Medication) (NN adherence)) (VP (VBZ is) (PP (IN of) (NP (NP (JJ utmost) (NN importance)) (PP (IN for) (NP (NP (JJ many) (JJ chronic) (NNS conditions)) (, ,) (ADVP (RB regardless) (PP (IN of) (NP (DT the) (NN disease) (NN type))))))))) (. .))
(S (NP (NP (VBG Engaging) (NNS patients)) (PP (IN in) (S (VP (NN self) (HYPH -) (VBG tracking) (NP (PRP$ their) (NN medication)))))) (VP (VBZ is) (NP (DT a) (JJ big) (NN challenge))) (. .))
(S (NP (NP (CD One) (NN way)) (PP (IN to) (S (ADVP (RB potentially)) (VP (VB reduce) (NP (DT this) (NN burden)))))) (VP (VBZ is) (S (VP (TO to) (VP (VB use) (NP (NNS reminders)) (S (VP (TO to) (VP (VP (VB promote) (NP (NN wellness)) (PP (IN throughout) (NP (NP (DT all) (NNS stages)) (PP (IN of) (NP (NN life)))))) (CC and) (VP (VB improve) (NP (NN medication) (NN adherence)))))))))) (. .))
(S (NP (NNS Chatbots)) (VP (VBP have) (VP (VBN proven) (NP (NP (NN effectiveness)) (PP (IN in) (S (VP (VBG triggering) (NP (NNS users)) (S (VP (TO to) (VP (VB engage) (PP (IN in) (NP (JJ certain) (NN activity))))))))) (, ,) (PP (JJ such) (IN as) (NP (NN medication) (NN adherence)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP discuss) (NP (NP (`` ") (NNP Roborto) ('' ")) (, ,) (NP (DT a) (NN chatbot) (S (VP (TO to) (VP (VP (VB create) (NP (DT an) (JJ engaging) (ADJP (JJ interactive) (CC and) (JJ intelligent)) (NN environment)) (PP (IN for) (NP (NNS patients)))) (CC and) (VP (VB assist) (PP (IN in) (NP (JJ positive) (NN lifestyle) (NN modification)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP introduce) (NP (NP (DT a) (NN way)) (PP (IN for) (NP (NN healthcare) (NNS providers)))) (S (VP (TO to) (VP (VP (VB track) (NP (NNS patients)) (NP (NN adherence))) (CC and) (VP (VB intervene) (SBAR (WHADVP (WRB whenever)) (FRAG (ADJP (JJ necessary))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP describe) (NP (NP (DT the) (NN health)) (, ,) (NP (JJ technical)) (CC and) (NP (JJ behavioural) (NNS approaches))) (PP (IN to) (NP (NP (DT the) (NN problem)) (PP (IN of) (NP (NN medication) (NN non-adherence)))))) (CC and) (VP (VB propose) (NP (NP (DT a) (JJ diagnostic)) (CC and) (NP (NN decision) (NN support) (NN tool))))) (. .))
(S (NP (DT The) (JJ proposed) (NN study)) (VP (MD will) (VP (VB be) (VP (VBN implemented) (CC and) (VBN validated) (PP (IN through) (NP (DT a) (NN pilot) (NN experiment))) (PP (IN with) (NP (NNS users))) (S (VP (TO to) (VP (VB measure) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (DT the) (VBN proposed) (NN approach)))))))))) (. .))
